Antibacterial activity of blue light against nosocomial wound pathogens growing planktonically and as mature biofilms by Halstead, Fenella D. et al.
Antibacterial Activity of Blue Light against Nosocomial Wound
Pathogens Growing Planktonically and as Mature Biofilms
Fenella D. Halstead,a,b,c Joanne E. Thwaite,d Rebecca Burt,a,c* Thomas R. Laws,d Marina Raguse,e Ralf Moeller,e Mark A. Webber,b,c
Beryl A. Oppenheima,b
Clinical Microbiology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdoma; NIHR Surgical Reconstruction
and Microbiology Research Centre, Queen Elizabeth Hospital, Birmingham, United Kingdomb; Institute of Microbiology and Infection, University of Birmingham,
Birmingham, United Kingdomc; Chemical, Biological and Radiological Division, Dstl, Porton Down, Salisbury, Wiltshire, United Kingdomd; German Aerospace Center (DLR
e.V.), Institute of Aerospace Medicine, Radiation Biology Department, Space Microbiology Research Group, Cologne, Germanye
ABSTRACT
The blue wavelengths within the visible light spectrum are intrinisically antimicrobial and can photodynamically inactivate the
cells of a wide spectrum of bacteria (Gram positive and negative) and fungi. Furthermore, blue light is equally effective against
both drug-sensitive and -resistant members of target species and is less detrimental to mammalian cells than is UV radiation.
Blue light is currently used for treating acnes vulgaris andHelicobacter pylori infections; the utility for decontamination and
treatment of wound infections is in its infancy. Furthermore, limited studies have been performed on bacterial biofilms, the key
growth mode of bacteria involved in clinical infections. Here we report the findings of a multicenter in vitro study performed to
assess the antimicrobial activity of 400-nm blue light against bacteria in both planktonic and biofilm growthmodes. Blue light
was tested against a panel of 34 bacterial isolates (clinical and type strains) comprising Acinetobacter baumannii, Enterobacter
cloacae, Stenotrophomonas maltophilia, Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, Enterococcus fae-
cium, Klebsiella pneumoniae, and Elizabethkingia meningoseptica. All planktonic-phase bacteria were susceptible to blue light
treatment, with the majority (71%) demonstrating a>5-log10 decrease in viability after 15 to 30 min of exposure (54 J/cm
2 to 108
J/cm2). Bacterial biofilms were also highly susceptible to blue light, with significant reduction in seeding observed for all isolates
at all levels of exposure. These results warrant further investigation of blue light as a novel decontamination strategy for the nos-
ocomial environment, as well as additional wider decontamination applications.
IMPORTANCE
Blue light shows great promise as a novel decontamination strategy for the nosocomial environment, as well as additional wider
decontamination applications (e.g., wound closure during surgery). This warrants further investigation.
Antimicrobial resistance (AMR) is rapidly evolving and emerg-ing to be a large threat to modern medicine. Although affect-
ing only a minority of admissions, health care-associated infec-
tions are associated with increased mortality, prolonged hospital
stays, and increased treatment costs (1).With the rise in resistance
to the carbapenem class of antibiotics in Gram-negative organ-
isms (2), there is a significant threat of infections becomingwholly
untreatable with current treatment regimens (3, 4).
Much research is now focused on alternatives to the conven-
tional antimicrobial agents. These mostly involve topical agents
(with the aim to reduce surface contamination and therefore
lower the risks of sepsis and infection progression) with research
to date on a large number of agents. Since the environment is a key
source of nosocomial pathogens (5), there has also been renewed
focus on hospital cleaning and disinfection, especially via antimi-
crobial chemicals delivered in a novel way, including antimicro-
bial light sources (1, 6). These novel strategies, capable of decon-
taminating both the patient’s wound and the environment, have
the potential to be highly beneficial in the fight against AMR and
nosocomial infections.
The blue wavelengths within the visible light spectrum (espe-
cially wavelengths between 400 and 470 nm) are intrinsically an-
timicrobial and do not require additional exogenous photosensi-
tizers to exert an antimicrobial effect (4). Photodynamic
inactivation of both bacterial and fungal cells occurs as a result of
photoexcitation of intracellular porphyrins (1) by blue light, lead-
ing to energy transfer and the production of highly cytotoxic re-
active oxygen species (ROS), primarily singlet oxygen (1O2) (4,
7–9). All wavelengths from 400 to 425 nm can be used for micro-
bial inactivation; however, the optimal antimicrobial activity oc-
curs at 405 nm, since this is the point in the electromagnetic spec-
trum where maximum porphyrin excitation occurs (10).
Although blue light is less germicidal thanUV light (1), pathogens
can be selectively inactivated without damaging human cells, and
consequently, blue light is considered much less detrimental to
mammalian cells than UV light (11, 12). One potential benefit of
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light-based antimicrobial therapies is equal efficacies against
drug-sensitive and resistant members of target species (13, 14).
Blue light has been shown to exhibit a broad spectrum of anti-
microbial effect against bacteria and fungi, although generally the
Gram-positive bacteria are considered more susceptible to blue
light than the Gram-negative bacteria (15, 16). Successful inacti-
vation has been demonstrated in vitro against Staphylococcus au-
reus (including methicillin-resistant S. aureus [MRSA]), Clostrid-
ium difficile (both spores and vegetative cells), Acinetobacter
baumannii, Escherichia coli, Staphylococcus epidermidis, Pseu-
domonas aeruginosa, Klebsiella pneumoniae, Streptococcus pyo-
genes, and Mycobacterium spp. (14, 15, 17, 18). In addition to the
key nosocomial pathogens, blue light is also effective against Pro-
pionibacterium acnes and has been used topically to treat acne
vulgaris (19, 20) andHelicobacter pylori, in which case blue light is
used internally as a “light string” to treat stomach infections (21).
Owing to the mechanism of action of blue light, it is unlikely that
viruses will be susceptible unless photosensitizers are added to
enhance virucidal activity (22).
The use of blue light for treatment of wound infections in vivo
is an emerging technology. To date, blue light therapy has been
shown to significantly reduce the bacterial burden of wounds in-
fectedwithP. aeruginosa (23),MRSA (24), andA. baumannii (25),
and it saved the lives of mice subjected to potentially lethal burns
contaminated with P. aeruginosa and A. baumannii (23, 25).
As well as having clinical application for patient treatment,
blue light is also a promising candidate for the control of prob-
lematic microorganisms in the clinical setting (e.g., the disin-
fection of air and exposed surfaces). In this regard, Bache et al.
(26) and Maclean et al. (1) have performed studies with a new
disinfection technology termed the HINS-light environmental
decontamination system (EDS) which delivers low-irradiance
405-nm light continuously and is suitable for use in patient-
occupied settings. Evaluation studies performed by the latter
authors showed that there was a statistically significant 90%
reduction in numbers of culturable Staphylococci spp. following
24 h of use in an unoccupied room (5) and reductions of 56 to
86% when used in burn isolation rooms occupied by MRSA-
positive patients. Furthermore, when the system was no longer
used, the room became recontaminated to levels similar to
those pretreatment.
The vast majority of research on blue light has been carried out
on bacteria in the planktonic phase, dispersed evenly in a liquid
medium. In nature this is rarely the case, since most bacteria ag-
gregate to form complex communities within a matrix of extra-
cellular polymeric substances termed a biofilm. There are many
advantages for this compared to planktonic growth, including in-
creased resistance to killing via antimicrobials, immune cells,
chemicals, and environmental stresses (27). Furthermore, once a
biofilmhas become established on a surface, it is extremely hard to
eradicate. Medically, biofilms have been associated with a myriad
of chronic infections, acute infections, colonization of indwelling
medical devices, and wound infections (27–29).
Since we know that the majority of clinical infections and en-
vironmental contamination involve microbial biofilms (30), this
multicenter in vitro studywas performed to assess the antibacterial
activity of blue light against biofilms of a range of important nos-
ocomial pathogens.
MATERIALS AND METHODS
A series of in vitro experiments were conducted with a panel of organisms
(Table 1) to determine the efficacy of blue light (400 nm) against bacteria
in planktonic (free-floating in broth) and biofilm (attached to a surface)
modes of growth. The panel comprised well-characterized control and
clinical isolates (in terms of their antibiograms and abilities to form bio-
films in vitro) and concentrated mostly on A. baumannii strains from a
protracted outbreak at the Queen Elizabeth Hospital in Birmingham
(QEHB) (31). A. baumannii is a key nosocomial pathogen which survives
in hospital and health care environments despite conditions such as des-
iccation, nutrient starvation, and antimicrobial chemicals (e.g., disinfec-
tants) (32, 33). Despite stringent infection control practices, a large out-
break of A. baumannii occurred at QEHB, where 65 patients tested
positive during the outbreak period (July 2011 to February 2013). The
strains from this outbreak demonstrated a high degree of resilience in the
hospital environment, and there was also evolution among the isolates
over time to increase desiccation resistance and biofilm formation capac-
ity. Additional A. baumannii isolates (representing genetically diverse
strains) were tested in this panel to add some diversity to the strains,
including strains ACI_AYE (a representative of international clone I, a
major globally relevant lineage), ACI_C60 (a control strain of a unique
pulsed-field gel electrophoresis [PFGE] type), and ACI_19606 (a control
strain of a further unique PFGE type) (typing data not shown).
We also tested a small range of other comparator organisms com-
monly causing hospital-acquired infections, including Enterobacter cloa-
cae, Stenotrophomonas maltophilia, P. aeruginosa, E. coli, S. aureus, and
Enterococcus faecium, and we included control strains (PS_6749 and
MSSA_10788) recognized in the EN standards for assessing the efficacy of
chemical disinfectants (e.g., EN 13727 [34]). The panel comprised isolates
that in previous tests had demonstrated ability to form relevant quantities
of biofilm in vitro and furthermore included two carbapenem (multi-
drug)-resistant isolates of K. pneumoniae and a single isolate of Elizabeth-
kingia meningoseptica from a wound swab. This is an intrinsically highly
resistant organism, usually resistant to extended-spectrum -lactam
agents (due to production by most strains of two -lactamases: one ex-
tended-spectrum -lactamase [ESBL] and one class B carbapenem-hy-
drolyzing metallolactamase), aminogylcosides, tetracycline, and chlor-
amphenicol (35).
All isolates were stored at80°C on Protect beads and were routinely
cultured on cysteine lactose electrolyte-deficient (CLED) agar or blood
agar prior to each experiment.
Experiments were designed to assess the antibacterial activity of blue
light against planktonic and biofilm growth forms of the panel of bacteria
described above. Testing was performed at the Defense Science Technol-
ogy Laboratory (Dstl) (planktonic growth) and the Surgical Reconstruc-
tion and Microbiology Research Centre (biofilms), and blue light of a
400-nm wavelength was used for all experiments.
Blue light equipment. High-intensity blue light was provided by a
LED flood array (Henkel-Loctite, Hemel Hempstead, United Kingdom).
This array utilizes 144 reflectorized LEDs which produce a homogeneous
illuminated area of 10 cm by 10 cm. The emission spectrum of the LED
array was determined using a USB2000 spectrophotometer (Ocean Op-
tics, Oxford, United Kingdom). Two identical platformswere used for the
testing, both of which were calibrated at Dstl using a PM100D radiant
power meter (Thorlabs, Newton, NJ) prior to in vitro testing to ensure a
reproducible irradiance of 60 mW/cm2 when the LED array is positioned
15.5 cm above the test area. All of the experimental conditions (except
wavelength) adhere to the optimal criteria outlined by Coohill and Sagri-
panti (36) for the assessment of bacterial sensitivity to UV-C radiation.
Impact of blue light on planktonic bacteria. Bacterial isolates were
grown overnight in Luria broth (LB; Sigma-Aldrich, United Kingdom)
and then diluted in sterile phosphate-buffered saline (PBS) to produce a
starting concentration of approximately 1  106 bacteria per ml. Test
samples (2 ml) were inoculated into a 12-well microtiter plate (Corning,
NY), sealed with an optically clear ABsolute quantitative PCR (qPCR)
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sealer (Thermo Fisher Scientific, Paisley, Scotland) to prevent evapora-
tion, and then exposed to blue light for 30 min (samples were taken for
viable cell counting at 5-min intervals). If the strains still showed viability
after 30 min of blue light exposure, the test was repeated over 180 min,
with samples taken at 20-min intervals. An identical dark control plate
was set up, wrapped in aluminum foil, and placed in the flood array
adjacent to the blue light-irradiated samples.
At time increments during the experiment, samples exposed to blue
light and incubated in the darkwere removed and viable bacteria enumer-
ated by serial dilution and growth on LB agar plates. The blue light sensi-
tivity for each strain was determined from the mean of three independent
biological replicates, with two technical replicates within each experi-
ment.
The blue light dose (joules per square centimeter) received by the
bacteria was calculated by multiplying the irradiance of light (watts per
square centimeter) to which the sample was exposed by the exposure time
(seconds).
Impact of blue light onpreformedbiofilms.The antibacterial activity
of blue light against preformed biofilms was assessed by conducting min-
imum biofilm eradication concentration (MBEC) experiments (37) on
each isolate.Overnight LB cultures of the test strains (made by inoculating
approximately three to five colonies into 5 ml of fresh LB and incubating
them at 37°C overnight) were diluted in fresh antibiotic-free Mueller-
Hinton (MH) broth to an optical density at 600 nm (OD600) of 0.1, and
then 200 l was seeded into wells of a 96-well microtiter tray (MTT).
Positive (200 l of organisms diluted to an OD600 of 0.1) and negative
(200 l of MH broth) controls were included per blue light time point to
be tested.
To produce a “transferable biofilm,” a 96-well polypropylene plate
(Starlabs, United Kingdom) was then placed into the MTT so that each
well contained a “peg” on which biofilms could form, before the plates
were sealed, and statically incubated at 33°C for 72 h. After 72 h, the pegs
(biofilm) were removed andwashed in anMTT containing sterile water
(to remove any unbound cells). The negative control (sterile broth only)
“peg plate” was then placed in a clean, empty MTT and wrapped in foil.
Following this, both the negative control and the positive test peg plate
(bacteria only) were placed in the test area (15.5.cm beneath the light
source) and exposed to the blue light for periods of 15, 30, 45, or 60 min
(corresponding to a blue light dose of 54, 108, 162, and 216 J/cm2, respec-
tively). The foil around the control plate prevented the pegs from receiv-
TABLE 1 Clinical and control isolates used in this studya
Study identifier Organism Description
ACI_616 Acinetobacter baumannii QEHB clinical outbreak isolate
ACI_618 Acinetobacter baumannii QEHB clinical outbreak isolate
ACI_642 Acinetobacter baumannii QEHB clinical outbreak isolate
ACI_648 Acinetobacter baumannii QEHB clinical outbreak isolate
ACI_659 Acinetobacter baumannii QEHB clinical outbreak isolate
ACI_665 Acinetobacter baumannii QEHB clinical outbreak isolate
ACI_671 Acinetobacter baumannii QEHB clinical outbreak isolate
ACI_672 Acinetobacter baumannii QEHB clinical outbreak isolate
ACI_698 Acinetobacter baumannii QEHB clinical outbreak isolate
ACI_AYE Acinetobacter baumannii MPR clinical isolate (unique)
ACI_C60 Acinetobacter baumannii NCTC 13424 (unique)
ACI_19606 Acinetobacter baumannii ATCC 19606 (unique)
ENTCL_525 Enterobacter cloacae complex QEHB clinical isolate
ENTCL_801 Enterobacter cloacae complex QEHB clinical isolate
ENTCL_804 Enterobacter cloacae complex QEHB clinical isolate
STEMA_529 Stenotrophomonas maltophilia QEHB clinical isolate
STEMA_551 Stenotrophomonas maltophilia QEHB clinical isolate
STEMA_558 Stenotrophomonas maltophilia QEHB clinical isolate
PSE_568 Pseudomonas aeruginosa QEHB clinical isolate
PSE_PA01 Pseudomonas aeruginosa ATCC 15692
PSE_6749 Pseudomonas aeruginosa NCTC 6749
PSE_1054 Pseudomonas aeruginosa QEHB clinical burn isolate
PSE_1586 Pseudomonas aeruginosa QEHB clinical burn isolate
EKIN_502 Elizabethkingia meningoseptica QEHB clinical isolate
EC_073 Escherichia coli EPEC CFT_073
EC_042 Escherichia coli EAEC_042
MDR_A CPE Klebsiella pneumoniae (NDM-1 positive) QEHB clinical isolate
MDR_B CRE Klebsiella pneumoniae (ESBL positive with
additional permeability changes)
QEHB clinical isolate
MRSA_508 Staphylococcus aureus QEHB clinical isolate
MRSA_520 Staphylococcus aureus QEHB clinical isolate
MRSA_531 Staphylococcus aureus QEHB clinical isolate
MSSA_10788 Staphylococcus aureus NCTC 10788
MSSA_F77 Staphylococcus aureus NCTC 8532
EFM_513 Enterococcus faecium QEHB clinical isolate
MSSA_29213 Staphylococcus aureus ATCC 29213
MSSA_10442 Staphylococcus aureus NCTC 10442
MSSA_33807 Staphylococcus aureus ATCC 33807
MSSA_4163 Staphylococcus aureus NCTC 4163
a MPR, Ministry of Research, Paris; CPE, carbapenemase-producing Enterobacteriaceae; NDM-1, New Delhi metallo--lactamase; CRE, carbapenem-resistant Enterobacteriaceae;
ESBL, extended-spectrum -lactamase.
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ing any blue light treatment (and hence these positive-control biofilms
were not exposed to the blue light), but the control plate biofilms would
have most likely been exposed to the same amount of heating and drying
as the blue light-exposed test plate.
After the treatment, the peg plates were carefully placed into an MTT
containing 200 l of sterile MH broth (herein referred to as reporter
broth) for overnight incubation. After 18 h, the OD of the reporter broth
was measured to assess the viability (seeding) of the biofilms following
blue light exposure.
To demonstrate the presence of biofilms on the pegs, crystal violet
(CV) assays were additionally performed on the pegs after the OD of the
reporter broth had been measured. This involved placing the pegs into
MTTs containing 200l of 1%CV (which binds to any present microbial
biomass of biofilm), followed by washing (to remove unbound CV) and
solubilization of the CV in 200 l of 70% ethanol. The peg biofilm bio-
mass could then be measured using OD readings as done previously and
the presence of the biofilm confirmed. Two biological and 10 technical
replicates were performed for each strain and blue light exposure dura-
tion, respectively.
Statistical analysis. (i) Planktonic tests. For the planktonic data, the
surviving fraction was determined from the quotient N/N0, with N being
the number of colony formers of the irradiated sample andN0 that of the
nonirradiated controls. Plotting the logarithm of N/N0 as a function of
dose (blue light fluence in joules per square centimeter) allowed survival
curves to be obtained.
To determine the curve parameters, the following relationship was
used: ln N/N0  IC  F  n, where N is the number of colony formers
after blue light irradiation, N0 is the number of colony formers without
irradiation, IC is the inactivation constant (in joules per square centime-
ter), F is fluence, and n is the extrapolation number (i.e., the interceptwith
the ordinate of the extrapolated semilog straight line). The inactivation
constant and the reciprocal lethal dose (LD) values were determined from
the slope of the dose-effect curves (linear portion of the curve).
To allow for comparison with other bactericidal radiation sources
in the literature, blue light-mediated killing was calculated in terms of the
inactivation constant slope (IC) and the kill kinetics, shown as the doses
required to kill 37% and 90%of the bacterial cells (LD37 and LD90, respec-
tively). The significance of the difference of the dose-effect curves was
statistically analyzed using Student’s t test. Differences with P values of
	0.05 were considered statistically significant.
LD90 values were analyzed using the statistical software package IBM
SPSS V21.0, were found to be log normal by QQ plot (data not shown),
and were consequently transformed to the logarithm of 10 prior to para-
metric analysis. Differences between bacterial species was investigated us-
ing a 1-way analysis of variance (ANOVA), and the suitability of the data
for parametric analysis was further established with the use of Levene’s
test for unequal variance (P 0.165).Where only one bacterial strain of a
species was available, this species was taken out of the analysis. Multiple
comparisons were made using Bonferroni’s correction. Similarly, the ef-
fect of pigmentation of S. aureus strains on susceptibility to blue light was
tested by using t tests without Welch’s correction, and suitability was
further tested using Levene’s test for unequal variance (P 0.984).
(ii) Biofilm tests. The ability of biofilms to seed new growth following
exposure to blue light was assessed by comparing the OD values at each
blue light time point versus that of the untreated (positive) control, and
significance was determined using Student’s t test. In order to investigate
any possible link between biofilm size and depth (colorimetry) and blue
light sensitivity, these two parameters were investigated throughQQplots
in SPSS (SPSS Statistics for Windows, version 21.0, IBM Corp., Armonk,
NY). Initial analysis suggested that a transformation of both parameters
by the logarithm of 10 was needed to render the data suitable for paramet-
ric analysis data not shown). Very little difference between the technical
replicates was observedwith regard to either parameter, and therefore, the
median of the log10 of the technical replicates was used for analysis. The
capacity for each strain to form a biofilm was taken from the average of
the OD values over the 4 time points for the positive control. Compari-
sons of biofilm values were made using 1-way ANOVA and Student’s t
tests (without Welch’s correction), and comparisons of variances were
made with F tests and Brown-Forsythe tests. The viability of each strain of
bacteria in biofilmwas analyzed by Bonferroni’s posttests across each time
point (SPSS). Where significant differences between the positive control
and the blue light occurred, the blue light was regarded as having an effect
from there on, leading to an ordinal score for each strain of 15 min (54
J/cm2), 30 min (108 J/cm2), 45 min (162 J/cm2), 60 min (216 J/cm2), or

60 min. Comparisons of biofilm sensitivity scores were made using
Kruskal-Wallis tests.
In order to characterize whether correlation existed between mea-
sured parameters, Spearman’s method was used. In order to determine
the statistical power of the correlations, the computer program SPSS sam-
ple power V3.0 (IBM) was used, and power was calculated for one sample
correlations using the derived R value and the sample size (n 34).
RESULTS
Blue light was tested against 34 bacterial isolates, including clinical
isolates from QEHB and culture collection type strains. The re-
sults of the spectral output testing of the blue light platform (with
an Ocean Optics USB2000 spectrometer) determined that the
emission peak of the blue light produced was at 400 nm, with a
full-width half-maximum value of 8.5 nm (see Fig. S1 in the
supplemental material).
Sensitivity of isolates to blue lightwhen grown in planktonic
culture. All 34 isolates were sensitive to blue light treatment, and
there was no significant decay in the dark incubated controls. In
contrast, rapid and substantive loss of viability was observed
where all test bacteria were exposed to blue light (Fig. 1).
Twenty-four of the isolates (71%) demonstrated at least a
5-log10 decrease in viability following 15min (54 J/cm
2) to 30min
(108 J/cm2) of blue light exposure (Table 2), and for the majority
of these isolates (A. baumannii [12/12], S. aureus [4/5], S. malto-
philia [2/3], and E. meningoseptica [1/1]), there was a 
6-log10
decrease in viability. Ten of the 34 isolates showed a 	5-log10
decrease in viability. The isolates concerned included E. cloacae
(ENTCL_525, ENTCL_801, and ENTCL_804), E. coli (EC_073
and EC_042), K. pneumoniae (MDR_A and MDR_B), S. aureus
(MSSA_10788), S. maltophilia (STEMA_551), and E. faecium
(EFM_513). Four of the 34 isolates (E. cloacae ENTCL_525,
ENTCL_801, and ENTCL_804 and E. faecium EFM_513) took
longer to kill than the majority of isolates, requiring extended
periods up to 120min (432 J/cm2) to obtain 2- to 3-log10 decrease
in viability.
Loss of bacterial viability associated with blue light was calcu-
lated as previously described to give LD90 values in terms of joules
per square centimeter. Investigation of these LD90 values indi-
cated that differences between the valueswere very likely driven by
differences in the blue light susceptibilities of different bacterial
species (P 	 0.001). We found that the highest LD90 values be-
longed to E. cloacae and K. pneumoniae strains, which had values
statistically higher than all other species included in the analysis
(where more than one representative strain was tested) (P	 0.05
in all cases) (Fig. 2). The exception to this was E. coli, which had
moderate blue light tolerance, but no statistical differences were
seen between the strains tested.A. baumannii, S. aureus, P. aerugi-
nosa, and S. maltophilia all had similar and low levels of resistance
to the blue light exposure.
In the initial assay of planktonic cell resistance to blue light, we
observed that the S. aureus strains demonstrated different colony
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pigmentations, appearing as either pale yellow (MRSA_508,
MRSA_520, MRSA_531, and MSSA_F77) or orange (MSSA_
10788) when grown on LB agar. We hypothesized that this pig-
mentation may be responsible for the variability seen in both the
survival fraction curves and LD90 values when exposed to blue
light (Fig. 1B and 2). Four additional culture collection strains of
S. aureuswere assessed for blue light sensitivity, including two pale
yellow (MSSA_29213 and MSSA_10442) and two orange (MSSA_
33807 and MSSA_4163) strains. In total, nine strains of S. aureus
were tested, six yellow and three orange. We determined that the
orange pigmentation correlated with increased resistance to blue
light in both the survival fraction curves and in LD90 values (Fig. 3).
The LD90 values were statistically significantly higher in the orange-
pigmented strains than in their yellow counterparts (P 0.003).
FIG 1 Survival of planktonic bacteria after exposure to 400-nm blue light. (A) Acinetobacter baumannii strains are represented as follows: ACI_616, closed
circles; ACI_618, open circles; ACI_AYE, closed triangles; ACI_665, open triangles; ACI_19606, closed inverted triangles; ACI_648, open inverted triangles;
ACI_659, closed diamonds; ACI_C60, open diamonds; ACI_671, closed squares; ACI_672, open squares; ACI_698, closed hexagons; and ACI_642, open
hexagons. (Note that the hexagons are behind the other symbols.) (B) Staphylococcus aureus strains are represented as follows: MSSA _10788, open circles;
MSSA_F77, closed triangles;MRSA_520, closed squares;MRSA_531, open triangles; andMRSA_508, closed circles. (C) Stenotrophomonasmaltophilia strains are
represented as follows: STEMA_ 558, triangles; STEMA_551, circles; and STEMA_529, squares. (D) Enterobacter cloacae strains are represented as follows:
ENTCL_804, circles; ENTCL_801, triangles; and ENTCL_525, squares. (E) Pseudomonas aeruginosa strains are represented as follows: PSE_1586, closed circles;
PSE_PAO1, open circles; PSE_568, closed triangles; PSE_1054, closed squares; and PSE_6479, open squares. (F) Other strains are represented as follows: E. coli
EC_042, open circles;E. coliEC_073, closed circles;K. pneumoniaeMDR-A, open squares;K. pneumoniaeMDR-B, closed squares;Elizabethkingiameningoseptica
EKIN_502, open triangles; and Enterococcus faecium EFM_513, open inverted triangles. Data are averages standard deviations (n 3).
Halstead et al.












Sensitivities of isolates to blue light when grown in biofilms.
Blue light treatment resulted in reductions in biofilm seeding for
all isolates tested (Fig. 4), and the majority of these reductions
(apart from the time point of 15 min for MSSA_10788) were sta-
tistically significant (P	 0.05 in Student’s t tests compared to the
positive control). The percentage reductions are shown in Table 3,
with the single nonsignificant result indicated by a caret.
The most susceptible isolates were the Gram-negative organ-
isms, in particular ACI_19606, for which therewas a 93.5% reduc-
tion in biofilm seeding (P	 0.001) after 15min (54 J/cm2) of blue
light exposure. As a group, the other Gram-negative comparator
organisms were the most susceptible, with 10/16 (63%) showing
greater than 80% reductions in biofilm seeding (average 86%)
at 15 min, compared to 1/12 for A. baumannii and 1/6 for the
Gram-positive organisms. Although ENTCL_804 responded well
to blue light treatment for 30min at 108 J/cm2 (46.6% reduction),
45 min at 162 J/cm2 (88.2% reduction), and 60 min at 216 J/cm2
(87.8% reduction), the treatment actually resulted in increased
biofilm seeding at 15min of 18.7%. This result was repeatable and
was seen in a number of replicates.
Asmentioned above, the Gram-positive biofilms were less sus-
ceptible to blue light treatment, with only two isolates (33%)
achieving at least 90% reductions in seeding. It is important to
note, however, the small sample size. One isolate of S. aureus
(MSSA_10788), which is recognized in the EN standards for as-
sessing the efficacy of chemical disinfectants, was the least sensi-
tive to blue light, achieving amaximum reduction in biofilm seed-
ing of 36% at 45min (162 J/cm2). This result was again repeatable
















ACI_616 30 60 108 7.06 0.006 21 2 27 2
ACI_618 30 60 108 5.78 0.007 55 4 59 3
ACI_642 30 60 108 6.73 0.006 9 1 16 2
ACI_648 30 60 108 6.14 0.007 21 2 29 3
ACI_659 30 60 108 6.55 0.006 8 1 16 2
ACI_665 30 60 108 6.14 0.006 7 1 12 1
ACI_671 30 60 108 6.34 0.006 25 2 32 4
ACI_672 30 60 108 6.22 0.006 16 2 24 2
ACI_698 30 60 108 6.39 0.008 9 1 14 2
ACI_AYE 30 60 108 6.70 0.006 10 1 16 2
ACI_C60 30 60 108 6.76 0.007 7 1 14 1
ACI_19606 30 60 108 6.81 0.006 7 1 13 1
ENTCL_525 100 60 360 6.76 0.006 113 12 136 19
ENTCL_801 180 60 648 6.61 0.009 212 20 246 25
ENTCL_804 160 60 576 6.24 0.007 258 18 306 24
STEMA_529 30 60 108 7.21 0.006 7 1 12 2
STEMA_551 30 60 108 2.97 0.006 26 3 48 5
STEMA_558 30 60 108 7.33 0.006 8 1 18 2
PSE_568 30 60 108 6.48 0.002 6 1 12 2
PSE_PA01 30 60 108 5.59 0.001 6 1 17 3
PSE_6749 30 60 108 6.55 0.009 7 1 13 2
PSE_1054 30 60 108 6.01 0.002 9 1 15 2
PSE_1586 30 60 108 6.07 0.002 13 2 22 2
EKIN_502 15 60 54 6.79 0.006 1 0.5 4 3
EC_073 30 60 108 4.71 0.006 56 4 64 7
EC_042 30 60 108 1.55 0.006 74 8 85 9
MDR_A 140 60 504 6.88 0.002 124 18 159 25
MDR_B 140 60 504 6.61 0.007 185 16 219 22
MRSA_508b 30 60 108 6.17 0.002 12 1 21 3
MRSA_520b 15 60 54 6.82 0.002 1 0.5 5 1
MRSA_531b 30 60 108 6.41 0.001 7 1 15 2
MSSA_10788c 80 60 288 7.07 0.001 99 12 118 15
MSSA_ F77b 30 60 108 6.76 0.006 3 1 12 2
EFM_513 180 60 648 1.86 0.007 277 16 393 20
Additional S. aureus isolates
(for pigmentation
investigation)
ATCC 29213b 30 60 108 6.76 0.002 5 1 15 2
NCTC 10442b 30 60 108 6.69 0.002 8 1 20 2
ATCC 33807c 80 60 288 7.01 0.002 15 2 40 5
NCTC 4163c 80 60 288 6.07 0.003 38 5 71 6
a Values are means standard deviations.
b Yellow pigmentation.
c Orange pigmentation.
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and was seen in 48 replicate pegs. This is further evidence toward
the hypothesis that bacterial pigmentation attenuates the sensitiv-
ity to blue light in biofilms as well as in planktonic cells.
In order to characterize how the different biofilm forming
properties (seeding ability and biofilm size) of each bacterial spe-
cies relate to each other, a series of correlations were performed.
We found no evidence for significant correlations existing be-
tween (i)median biofilm size (CV assay) andmedian sensitivity of
biofilm to blue light (P  0.133) or (ii) median biofilm size and
LD90 (P  0.912). For these reasons, we feel that any differences
between species in biofilm resistance to blue light are likely to be
intrinsic differences rather than a function of the biofilm. How-
ever, we are not able to dismiss the alternative hypothesis that
correlations do exist, as these analyses were insufficiently pow-
ered. We found the statistical power to be 21% when considering
the potential correlation between planktonic and biofilm killing
(R  0.200) and 33% when considering the correlation between
biofilm killing and biofilm formation (R  0.263). In this re-
spect, we must actually conclude that real correlations between
these parameters might exist; however, if they do exist, they are
likely to less apparent than the correlation observed between bio-
film formation and planktonic killing.
We found a significant correlation between the sensitivity of
strains to blue light in the planktonic state and their ability to form
biofilms (Spearman’s coefficient 0.369; P 0.032). This indicated
that strains that demonstrated greater resistance to blue light in the
planktonic state were more likely to produce thicker biofilm.
DISCUSSION
In this study, we have shown blue light (400 nm) to be effective at
inactivating both planktonic cells and biofilms of important nos-
ocomial wound pathogens. Contrary to published research (1, 15,
16), we foundGram-negative organisms to bemore susceptible to
blue light. There are a number of differences between these pub-
lished studies and our study which may contribute to these con-
flicting findings. First, we tested a number of isolates per species
(most of the studies test one strain of each species) comprising
both clinical and control strains (most of the published studies use
control strains which may have been passaged many times), and
our light box exposed the bacteria to higher doses (60 mW/cm2)
than the 10 mW/cm2 used by Maclean et al. (15). Although we
only tested a small number of isolates, the Gram-positive biofilms
appeared less sensitive to blue light treatment, with one strain
(MSSA_10788) consistently resisting the effects of blue light.
Analyzing blue light susceptibility against multiple clinical
strains from the same species has permitted us to assess the heter-
ogeneity of intraspecies kill rates. In some species, such as A. bau-
mannii, the rate of blue light-mediated killing was extremely ho-
FIG 2 Comparison of blue light LD90 values between strains and species. Each
individual circle represents the average LD90 for each strain  the standard
deviations (n  3). The average LD90 values for the species are shown by
horizontal lines.
FIG 3 (A) Correlation between survival of planktonic S. aureus strains follow-
ing blue light exposure and cell pigmentation. Orange carotenoid-producing
strains are represented as follows: MSSA_4163, closed circles; MSSA_33807,
closed inverted triangles; and MSSA_10788, closed triangles. Yellow non-car-
otenoid-producing strains are represented as follows: MSSA_10442, open cir-
cles;MSSA_F77, open squares;MRSA_520, open diamonds;MRSA_531, open
inverted triangles; MRSA_508, open triangles; and MSSA_29213, open hexa-
gons.Data are averages standard deviations (n 3). (B)Comparison of blue
light LD90 values between yellow- and orange-pigmented S. aureus strains.
Each individual circle represents the average LD90 for each strain the stan-
dard deviation (n  3). The average LD90 values for yellow- and orange-
pigmented strains are shown by horizontal lines.
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mogeneous; however, S. aureus strains display a much more
heterogeneous response to blue light stress.
It has long been recognized that bacterial cells have utilized
pigmentation as a virulence factor (38). Among the most easily
recognizable bacterial pigments are the triterpenoid carotenoids,
which impart the eponymous golden color to S. aureus strains.
Various authors have identified a correlation between strains con-
taining the carotenoid pigment staphyloxanthin and the ability to
survive on surfaces exposed to natural sunlight (39), and it is well
known that carotenoids function as antioxidants. Furthermore,
staphyloxanthin has been shown to provide protection for pig-
mented S. aureus strains against ROS produced by phagocytes
(40, 41).
Augmentation of the clinical isolates of S. aureus with a series
of well-characterized strains from culture collections allowed us
to correlate increased blue light killing times (as seen with
MSSA_10788) with colony pigmentation. Planktonic testing and
assessment of the LD90 values per color group showed that the
light sensitivity of the strongly orange-pigmented strains is signif-
icantly different from that of the standard pale yellow strains (P
value	 0.003) (Fig. 3B). Therefore, although all species of S. au-
reus tested were susceptible to blue light, it is important to con-
sider the effects of bacterial pigmentation when determining the
required blue light exposure for effective decontamination.
As well as differences in sensitivity, there were also several in-
stances where blue light treatment increased the planktonic
growth and biofilm seeding. For example, with ENTCL_804, there
was an increase of 18.7% in seeding after 15 min of blue light
treatment. Light has been shown to facilitate growth when the
wavelengths and dose are not appropriate (42), and Nussbaum et
FIG 4 Graphs showing the biofilm seeding results for all isolates. Optical density on the y axis refers to the average biofilm seeding for the isolates tested after
exposure to blue light at the range of durations tested (in minutes) on the x axis. The positive control was to the average biofilm seeding of the dark-incubated,
non-blue-light-exposed isolates. The negative control was to a negative (broth-only) control. The error bars represent the standard errors.
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al. (43) found that wavelengths of 810 nm and 905 nm improved
the growth of E. coli and S. aureus, respectively. Furthermore,
Mussi et al. (44) reported that blue light treatment decreased mo-
tility and biofilm formation inA. baumannii and increased patho-
genesis when coculturedwithCandida albicans (amodel for apop-
tosis in human alveolar macrophages) (45). However, there are
several important differences between the studies; the fluence was
considerably lower than in this study (1.32 to 1.89 mW/cm2
versus 60 mW/cm2) and the light wavelength peaked at 460 nm
versus 400 nm, while the exposure was measured over 4 days ver-
sus 30 min. However, it does raise interesting questions on the
effects of suboptimal light exposure on bacterial cells, which
should be looked into in future studies. Furthermore, the en-
hanced growth in our study warrants further investigation.
We found that a correlation existed between the strains which
were sensitive to blue light in the planktonic state and those which
produced larger amounts of biofilm in the CV assay. The reason
for this observation is not clear; however, we hypothesize that this
indicates that blue light selective pressuremay exist in environmental
niches where protection as a biofilm might provide benefits against
other stimuli that are likely to coexist with blue light. The fact that we
were unable to observe a correlation between biofilm and planktonic
resistance to blue light might indicate that these mechanisms are
functionally independent. Planktonic cells need to rely on their in-
trinsic transparency, pigmentation, and repair to protect against blue
light. In biofilm, bacteria can rely onmore extracellular exudate and
neighbors to protect against blue light.
To the best of our knowledge, our work is one of the first to
show the antibacterial activity of 400-nm light against a range of
clinically relevant bacterial strains (as well as control strains) and
one of just a handful to look at nondental biofilms. The inclusion
of multiple isolates is an additional strength of our study, as it
allows correlations between phenotypic characteristics and blue
light resistance to be explored. Although there are several limita-
tions (monomicrobial biofilms tested instead of polymicrobial,
the lack of formal assessment of the potential for the development
for resistance, the relatively small number of isolates tested, and
the potential biasing effect of the included resistant isolates), our
work nonetheless provides valuable insights into this technology
and especially how it relates to the eradication of biofilms for
environmental decontamination.
The findings in this paper demonstrate that high-intensity blue
light can be used to inactivate a wide range of clinical pathogens,
not only in the planktonic state but also as mature biofilms. This
technology hasmany practical applications within health care set-
tings, as blue light may ameliorate opportunistic infections indi-
rectly by reducing the bacterial load on environmental surfaces
and directly within wounds. Future studies are warranted to in-
vestigate this further, especially whether the exposure times of the
400-nm blue light can be reduced for a range of different clinical
applications. As blue light is equally efficacious against antibiotic-
resistant pathogens, this technology may prove an important
weapon in the future fight against antimicrobial resistance.
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